Sun Zeng-Feng, Fan Bo-Shi, Liu Jun-Qiang, Di Shou-Yin, Yue Cai-Ying, Zhao Jia-Hua, Wang Ju-Si, Song Wei-An, Lu Jing, Zhang Jia-Le, Gong Tai-Qian
Department of Thoracic and Cardiovascular Surgery, People's Hospital of Deyang City, Deyang, China.
Department of Thoracic Surgery, the Sixth Medical Center of PLA General Hospital, Beijing, China.
Transl Cancer Res. 2024 Jul 31;13(7):3437-3445. doi: 10.21037/tcr-23-2356. Epub 2024 Jul 12.
Whether patients can benefit from three-field lymphadenectomy (3-FL) in minimally invasive esophagectomy (MIE) remains unclear. This study retrospectively compared short-term outcomes between 3-FL and two-field lymphadenectomy (2-FL) in MIE for patients with esophageal cancer (EC) and aimed to evaluate the clinical significance of 3-FL.
There were 284 patients enrolled in the study (124 patients with 3-FL and 160 patients with 2-FL). The cases were matched based on their propensity scores using a matching ratio of 1:1, the nearest neighbor matching protocol, and a caliper of 0.02. Patients were propensity-score matched for sex, cancer location, Age-adjusted Charlson Comorbidity Index (ACCI), and neoadjuvant treatment. The short-term outcomes were postoperative complications, operation characteristics, pathology results and postoperative hospital stay.
There were no significant differences in intraoperative hemorrhage, postoperative hospital stay, or postoperative complications between the 2-FL and 3-FL groups. The operation time of the two groups was significantly different (227.1±46.2 248.5±45.9 min, P=0.001); the operation time of the 3-FL group was about 20 minutes longer than that of the 2-FL group. The number of lymphatic nodes (LNs) obtained in the 3-FL group was significantly higher than that in the 2-FL group (31.3±12.9 54.6±18.0, P<0.001). Pathological N stage was also significantly different (P=0.002); the 3-FL group was more advanced than the 2-FL group.
Compared to 2-FL MIE, 3-FL MIE does not increase postoperative complications, can obtain more LNs, and improves the accuracy of tumor LN staging.
在微创食管癌切除术(MIE)中,患者是否能从三野淋巴结清扫术(3-FL)中获益仍不明确。本研究回顾性比较了MIE中3-FL与二野淋巴结清扫术(2-FL)治疗食管癌(EC)患者的短期结局,旨在评估3-FL的临床意义。
本研究共纳入284例患者(124例行3-FL,160例行2-FL)。采用1:1的匹配比例、最近邻匹配方案和0.02的卡尺,根据倾向评分对病例进行匹配。患者在性别、肿瘤位置、年龄调整的Charlson合并症指数(ACCI)和新辅助治疗方面进行倾向评分匹配。短期结局包括术后并发症、手术特征、病理结果和术后住院时间。
2-FL组和3-FL组在术中出血、术后住院时间或术后并发症方面无显著差异。两组手术时间差异有统计学意义(227.1±46.2对248.5±45.9分钟,P = 0.001);3-FL组手术时间比2-FL组长约20分钟。3-FL组获得的淋巴结(LN)数量显著高于2-FL组(31.3±12.9对54.6±18.0,P < 0.001)。病理N分期也有显著差异(P = 0.002);3-FL组比2-FL组更高级。
与2-FL MIE相比,3-FL MIE不会增加术后并发症,能获得更多LN,并提高肿瘤LN分期的准确性。